California molecular diagnostics maker CardioDx takes another swing at an initial public offering and adds a few members to its leadership team.
More than 5 months after ditching efforts to open on public markets, California-based CardioDx is ready to take another swing at an initial public offering.
In regulatory documents filed this week the molecular diagnostics maker assigned new underwriters, named a couple of new executives and added 2 members to its board of directors. CardioDx has not yet revealed exact timing or terms for the revived IPO.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1nHybde
Cap comentari:
Publica un comentari a l'entrada